Fecal microbiota transplantation may transmit COVID-19, FDA warns

The FDA warned clinicians the SARS-CoV-2 virus, which causes COVID-19, may be transmitted in fecal samples during fecal microbiota transplants.

What you should know:

1. Although transmission risk during FMT remains unknown, because of the possibility, the FDA has recommended additional safety precautions.

2. The FDA recommends clinicians or researchers use stool donated before Dec. 1, 2019, whenever possible.

3. If stool from before Dec. 1 is not available, clinicians or researchers should screen donors for COVID-19, test donors or the stool for COVID-19, and develop informed consent forms that warn of potential transmission.

Read the entire briefing here.

More articles on ASC news:
Regent Surgical Health responds to COVID-19: 3 things to know
When will the coronavirus peak? It's complicated
Hospitals looking into using ASCs for COVID-19 patients: 4 things to know

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers